| ［1］ |
Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus⁃based interdisciplinary guidelines［J］. Eur J Cancer, 2019,118:10⁃34. doi: 10.1016/j.ejca.2019.06.003.
|
| ［2］ |
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016［J］. Lancet, 2018,391（10136）:2236⁃2271. doi: 10.1016/S0140⁃6736（18）30994⁃2.
|
| ［3］ |
Wu S, Han J, Li WQ, et al. Basal⁃cell carcinoma incidence and associated risk factors in U.S. women and men［J］. Am J Epidemiol, 2013,178（6）:890⁃897. doi: 10.1093/aje/kwt073.
|
| ［4］ |
涂庆峰, 吕婷, 赖永贤, 等. 上海市某社区老年人皮肤肿瘤流行病学研究［J］. 老年医学与保健, 2013,19（3）:142⁃145,148. doi: 10.3969/j.issn.1008⁃8296.2013⁃05.
|
| ［5］ |
郑博文, 邹勇莉, 何黎, 等. 皮肤恶性肿瘤568例回顾性分析［J］. 中国皮肤性病学杂志, 2009,23（12）:808⁃809,818.
|
| ［6］ |
黄远深, 李航, 涂平, 等. 632例皮肤恶性肿瘤及癌前病变临床分析［J］. 中华皮肤科杂志, 2010,43（7）:452⁃454. doi: 10. 3760/cma.j.issn.0412⁃4030.2010.07.002.
|
| ［7］ |
陈娜, 张良, 陈柳青. 皮肤恶性肿瘤及癌前病变3163例临床分析［J］. 临床皮肤科杂志, 2020,49（8）:456⁃459. doi: 10. 16761/j.cnki.1000⁃4963.2020.08.004.
|
| ［8］ |
陈自学, 周美杉, 涂平, 等. 418例基底细胞癌病例临床病理特点回顾分析［J］. 北京大学学报（医学版）, 2014,46（2）:195⁃199. doi: 10.3969/j.issn.1671⁃167X.2014.02.004.
|
| ［9］ |
高蓉梅. 109例皮肤基底细胞癌临床病理特点分析［J］. 医药前沿, 2018,8（3）:74⁃75.
|
| ［10］ |
McKenzie CA, Chen AC, Choy B, et al. Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting［J］. Pathology, 2016,48（5）:395⁃397. doi: 10.1016/j.pathol.2016.05.005.
|
| ［11］ |
Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi⁃centre case⁃case⁃control study［J］. Br J Cancer, 2006,94（5）:743⁃751. doi: 10.1038/sj.bjc.6602982.
|
| ［12］ |
Bonilla X, Parmentier L, King B, et al. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma［J］. Nat Genet, 2016,48（4）:398⁃406. doi: 10. 1038/ng.3525.
|
| ［13］ |
Jayaraman SS, Rayhan DJ, Hazany S, et al. Mutational landscape of basal cell carcinomas by whole⁃exome sequencing［J］. J Invest Dermatol, 2014,134（1）:213⁃220. doi: 10.1038/jid.2013.276.
|
| ［14］ |
Bresler SC, Padwa BL, Granter SR. Nevoid basal cell carcinoma syndrome （Gorlin syndrome）［J］. Head Neck Pathol, 2016,10（2）:119⁃124. doi: 10.1007/s12105⁃016⁃0706⁃9.
|
| ［15］ |
AlSabbagh MM, Baqi MA. Bazex⁃Dupré⁃Christol syndrome: review of clinical and molecular aspects［J］. Int J Dermatol, 2018,57（9）:1102⁃1106. doi: 10.1111/ijd.14065.
|
| ［16］ |
中国中西医结合学会皮肤性病专业委员会皮肤影像学组, 中国医疗保健国际交流促进会皮肤科分会皮肤影像学组, 中华医学会皮肤性病学分会皮肤病数字化诊断亚学组, 等. 中国基底细胞癌皮肤镜特征专家共识（2019）［J］. 中华皮肤科杂志, 2019,52（6）:371⁃377. doi: 10.3760/cma.j.issn.0412⁃4030. 2019.06.001.
|
| ［17］ |
中华医学会皮肤性病学分会皮肤肿瘤研究中心, 中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤鳞状细胞癌规范化诊疗共识（2021）［J］. 中华皮肤科杂志, 2021,54（8）:653⁃664. doi: 10.35541/cjd.20201140.
|
| ［18］ |
National Comprehensive Cancer Network. Basal cell skin cancer, version 2.2021, NCCN clinical practice guidelines in oncology［Z/OL］. （2021⁃02⁃25） ［2021⁃07⁃01］. https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf.
|
| ［19］ |
Tanese K. Diagnosis and management of basal cell carcinoma［J］. Curr Treat Options Oncol, 2019,20（2）:13. doi: 10.1007/s11864⁃019⁃0610⁃0.
|
| ［20］ |
Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs′ micrographic surgery for basal⁃cell carcinoma of the face: randomised controlled trial［J］. Lancet, 2004,364（9447）:1766⁃1772. doi: 10.1016/S0140⁃6736（04）17399⁃6.
|
| ［21］ |
Van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs′ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow⁃up［J］. Eur J Cancer, 2014,50（17）:3011⁃3020. doi: 10.1016/j.ejca.2014. 08.018.
|
| ［22］ |
Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs′ micrographic surgery for primary and recurrent basal⁃cell carcinoma of the face: a prospective randomised controlled trial with 5⁃years′ follow⁃up［J］. Lancet Oncol, 2008,9（12）:1149⁃1156. doi: 10.1016/S1470⁃2045（08）70260⁃2.
|
| ［23］ |
李媛媛, 池丽俏. 手术切除治疗皮肤恶性肿瘤的效果与复发率分析［J］. 中国肿瘤临床与康复, 2020,27（5）:575⁃578. doi: 10.13455/j.cnki.cjcor.2020.05.17.
|
| ［24］ |
王彦. 慢Mohs显微外科手术治疗皮肤基底细胞癌的临床观察［J］. 中国医疗美容, 2019,9（7）:39⁃42. doi: 10.19593/j.issn.2095⁃0721.2019.07.010.
|
| ［25］ |
Tchanque⁃Fossuo CN, Eisen DB. A systematic review on the use of cryotherapy versus other treatments for basal cell carcinoma［J］. Dermatol Online J, 2018, 24（11）. doi: 10.5070/D32411042000.
|
| ［26］ |
Bath⁃Hextall F, Ozolins M, Armstrong SJ, et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal⁃cell carcinoma （SINS）: a multicentre, non⁃inferiority, randomised controlled trial［J］. Lancet Oncol, 2014,15（1）:96⁃105. doi: 10. 1016/S1470⁃2045（13）70530⁃8.
|
| ［27］ |
Ferreres JR, Macaya A, Jucgla A, et al. Hundreds of basal cell carcinomas in a Gorlin⁃Goltz syndrome patient cured with imiquimod 5% cream［J］. J Eur Acad Dermatol Venereol, 2006,20（7）:877⁃878. doi: 10.1111/j.1468⁃3083.2006.01552.x.
|
| ［28］ |
Miller BH, Shavin JS, Cognetta A, et al. Nonsurgical treatment of basal cell carcinomas with intralesional 5⁃fluorouracil/epinephrine injectable gel［J］. J Am Acad Dermatol, 1997,36（1）:72⁃77. doi: 10.1016/s0190⁃9622（97）70328⁃1.
|
| ［29］ |
Kowalzick L, Rogozinski T, Wimheuer R, et al. Intralesional recombinant interferon beta⁃1a in the treatment of basal cell carcinoma: results of an open⁃label multicentre study［J］. Eur J Dermatol, 2002,12（6）:558⁃561.
|
| ［30］ |
Kaplan B, Moy RL. Effect of perilesional injections of PEG⁃interleukin⁃2 on basal cell carcinoma［J］. Dermatol Surg, 2000, 26（11）:1037⁃1040. doi: 10.1046/j.1524⁃4725.2000.0260111037.x.
|
| ［31］ |
Glass LF, Jaroszeski M, Gilbert R, et al. Intralesional bleomycin⁃mediated electrochemotherapy in 20 patients with basal cell carcinoma［J］. J Am Acad Dermatol, 1997,37（4）:596⁃599. doi: 10.1016/s0190⁃9622（97）70178⁃6.
|
| ［32］ |
Wang H, Xu Y, Shi J, et al. Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta⁃analysis［J］. Photodermatol Photoimmunol Photomed, 2015,31（1）:44⁃53. doi: 10.1111/phpp.12148.
|
| ［33］ |
任媛, 王元元, 张军波, 等. 局部光动力疗法治疗皮肤恶性肿瘤的远期疗效评价［J］. 重庆医学, 2017,46（10）:1373⁃1374. doi: 10.3969/j.issn.1671⁃8348.2017.10.025.
|
| ［34］ |
Soleymani T, Abrouk M, Kelly KM. An analysis of laser therapy for the treatment of nonmelanoma skin cancer［J］. Dermatol Surg, 2017,43（5）:615⁃624. doi: 10.1097/DSS.0000000000001048.
|
| ［35］ |
Migden MR, Chang A, Dirix L, et al. Emerging trends in the treatment of advanced basal cell carcinoma［J］. Cancer Treat Rev, 2018,64:1⁃10. doi: 10.1016/j.ctrv.2017.12.009.
|
| ［36］ |
von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature［J］. J Am Acad Dermatol, 1984,10（6）:1043⁃1060. doi: 10.1016/s0190⁃9622（84）80334⁃5.
|
| ［37］ |
Wysong A, Aasi SZ, Tang JY. Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011［J］. JAMA Dermatol, 2013,149（5）:615⁃616. doi: 10.1001/jamadermatol.2013.3064.
|
| ［38］ |
Rowe DE, Carroll RJ, Day CL Jr. Long⁃term recurrence rates in previously untreated （primary） basal cell carcinoma: implications for patient follow⁃up［J］. J Dermatol Surg Oncol, 1989,15（3）:315⁃328. doi: 10.1111/j.1524⁃4725.1989.tb03166.x.
|
| ［39］ |
Rees JR, Zens MS, Gui J, et al. Non melanoma skin cancer and subsequent cancer risk［J］. PLoS One, 2014,9（6）:e99674. doi: 10.1371/journal.pone.0099674.
|
